食管癌围手术期不输血的可行性研究  

Study on the feasibility of no blood transfusion for patients with esophageal carcinoma during perioperation period

作　　者：吴培仁[1] 蔡建春[1] 许林[1] 洪明[1] 林天胜[1] 刘域[1] 

机构地区：[1]福建医科大学附属厦门第一医院肿瘤外科,厦门361003

出　　处：《中国肿瘤临床与康复》2008年第5期439-441,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的探讨围手术期不输血完成食管癌切除术的可行性。方法将2000年1月至2006年6月182例食管癌切除术按围手术期有无输血分为输血组(93例)和不输血组(89例),比较两组的相关指标。结果不输血组与输血组比较,手术前后外周血红蛋白、红细胞、血小板和术中出血量及术后感染性并发症发生率差异均无显著性(P>0.05);肿瘤复发率及3,5年生存率差异有显著性(P<0.05)。结论食管癌围手术期不输血是安全可行的。Objective To explore the feasibility of no blood transfusion for patients with esophageal carcinoma during perioperation period. Methods From Jan. 2000 to Jun. 2006,182 cases with esophageal carcinoma underwent esophagectomy. The patients were divided into 93 cases receiving blood transfusion group and 89 cases no-transfusion group. The data were analyzed between transfusion and no-transfusion groups. Results There were no differences in the hemoglobin, the red blood cell,the blood platelet, the amount of hemorrhage during operation and the rate of postoperative infection complication between the 2 groups（P 〉0.05）. There was difference in the tumor recurring rate and 3-,5-year survival rates（P 〈0. 05） between no-transfusion and transfusion groups. Conclusion No transfusion during perioperative period is safe and feasible for the patients with esophageal carcinoma.

关 键 词：食管肿瘤 围手术期 输血 

分 类 号：R735.1[医药卫生—肿瘤] R730.56[医药卫生—临床医学]